Details
Product Name in the RMS: octaplasLG
MR Number: SE/H/1866/001
Date of outcome: 10.08.2000
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Initial Application Informed Consent Biological: Blood Product Prescription Only |
Active Substances |
human plasma proteins 0 mg/ml |
Form | Solution for infusion |
MA Holder in the RMS |
Octapharma AB Sweden |
RMS | Sweden |
Date of last change | 25.09.2020 |
ATC-Code |
B05AA Blood substitutes and plasma protein fractions |
CMS Country | Domestic Product Name |
---|---|
Austria | Octaplas LG 45 - 70 mg/ml Infusionslösung |
Belgium | |
Bulgaria | |
Croatia | octaplasLG 45-70 mg/ml otopina za infuziju |
Czech Republic | octaplasLG |
Denmark | |
Estonia | OCTAPLASLG |
Finland | |
France | |
Hungary | OCTAPLASLG 45-70 mg/ml oldatos infúzió |
Ireland | OCTAPLAS Solution for Infusion |
Latvia | Octaplasma šķīdums infūzijām |
Lithuania | octaplasma infuzinis tirpalas |
Luxembourg | |
Malta | octaplasLG solution for infusion |
Netherlands | |
Norway | |
Poland | octaplasLG |
Romania | OctaplasLG 45-70 mg/ml solutie perfuzabila |
Slovak Republic | |
Slovenia | |
Spain | |
United Kingdom |
Documents | |
---|---|
no related documents available |